Stuart Cobb's most recent trade in Neurogene Inc was a trade of 6,797 Common Stock done at an average price of $15.2 . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neurogene Inc | Stuart Cobb | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.15 per share. | 14 May 2025 | 6,797 | 20,794 | - | 15.2 | 103,003 | Common Stock |
| Neurogene Inc | Stuart Cobb | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 42,900 | 42,900 | - | - | Employee Stock Option (Right to buy) | |
| Neurogene Inc | Stuart Cobb | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 7,200 | 27,591 | - | 0 | Common Stock | |
| Neurogene Inc | Stuart Cobb | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 34,450 | 34,450 | - | - | Stock Option (Right to Buy) | |
| Neurogene Inc | Stuart Cobb | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 20,391 | 20,391 | - | 0 | Common Stock |